J Carl Barrett - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J Carl Barrett

Showing results (161-170 of 210) with videos related to

Pageof 21

Sort By:

Cancer Discovery|August 21, 2020

Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint BlockadeQu Zhang, Jia Luo, Song Wu, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2017

Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung CancerSuresh S Ramalingam, James C-H Yang, Chee Khoon Lee, et al.

Oncotarget|December 17, 2017

Comparative analysis of primary <i>versus</i> relapse/refractory DLBCL identifies shifts in mutation spectrumDanielle M Greenawalt, Winnie S Liang, Sakina Saif, et al.

Scientific Reports|May 27, 2024

HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancerAnsh Kapil, Andreas Spitzmüller, Nicolas Brieu, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022

Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfoundKim N Chi, Alan Barnicle, Caroline Sibilla, et al.

Nature Communications|February 27, 2023

Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trialJuliann Chmielecki, Tony Mok, Yi-Long Wu, et al.

Clinical Epigenetics|October 4, 2025

Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samplesBarrett Nuttall, Daniel L Karl, Kathleen Burke, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2020

Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic ResponseBen Sidders, Pei Zhang, Kelly Goodwin, et al.

Molecular Cancer|December 2, 2025

Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancerMingchao Xie, Miljenka Vuko, Shashank Saran, et al.

Human Molecular Genetics|June 24, 2005

The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle proteinNatalay Kouprina, Adam Pavlicek, N Keith Collins, et al.

Pageof 21

Search research articles

Showing results (161-170 of 210) with videos related to

Sort By:

Pageof 21

Cancer Discovery|August 21, 2020

Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint BlockadeQu Zhang, Jia Luo, Song Wu, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2017

Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung CancerSuresh S Ramalingam, James C-H Yang, Chee Khoon Lee, et al.

Oncotarget|December 17, 2017

Comparative analysis of primary <i>versus</i> relapse/refractory DLBCL identifies shifts in mutation spectrumDanielle M Greenawalt, Winnie S Liang, Sakina Saif, et al.

Scientific Reports|May 27, 2024

HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancerAnsh Kapil, Andreas Spitzmüller, Nicolas Brieu, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022

Nature Communications|February 27, 2023

Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trialJuliann Chmielecki, Tony Mok, Yi-Long Wu, et al.

Clinical Epigenetics|October 4, 2025

Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samplesBarrett Nuttall, Daniel L Karl, Kathleen Burke, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2020

Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic ResponseBen Sidders, Pei Zhang, Kelly Goodwin, et al.

Molecular Cancer|December 2, 2025

Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancerMingchao Xie, Miljenka Vuko, Shashank Saran, et al.

Human Molecular Genetics|June 24, 2005

The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle proteinNatalay Kouprina, Adam Pavlicek, N Keith Collins, et al.

Pageof 21